(2023)
Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma.
JHEP REPORTS.
5,
9
(2023)
Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B.
SCIENTIFIC REPORTS.
13,
1
(2022)
Changes in the prevalence of hepatitis B and metabolic abnormalities among young men in Korea.
KOREAN JOURNAL OF INTERNAL MEDICINE.
37,
5
(2022)
Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels.
DIGESTIVE DISEASES AND SCIENCES.
67,
9
(2022)
Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis.
FRONTIERS IN ONCOLOGY.
12,
-
(2022)
Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy.
SCIENTIFIC REPORTS.
12,
1
(2022)
Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial.
GENOME MEDICINE.
14,
1
(2022)
Age and fibrosis index for the prediction of hepatocellular carcinoma risk in patients with high hepatitis B virus DNA but normal alanine aminotransferase.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY.
34,
1
(2022)
Incidence and risk factors for development of hepatocellular carcinoma at young age in patients with chronic hepatitis B.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY.
57,
1
(2021)
The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation-wide Cohort Study.
HEPATOLOGY.
74,
6
(2021)
Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response.
JOURNAL OF VIRAL HEPATITIS.
28,
10
(2021)
Impact of COVID-19 on Hepatocellular Carcinoma Management: A Multicountry and Region Study.
JOURNAL OF HEPATOCELLULAR CARCINOMA.
8,
1
(2021)
Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy.
HEPATOLOGY INTERNATIONAL.
15,
4
(2021)
Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events.
DIGESTIVE DISEASES AND SCIENCES.
66,
8
(2021)
Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure.
DIGESTIVE AND LIVER DISEASE.
53,
8
(2021)
Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease.
NUTRIENTS.
13,
3
(2021)
Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance: potential implications for surveillance goal.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY.
56,
3
(2021)
A comparison of factors associated with the temporal improvement in the overall survival of BCLC stage 0 hepatocellular carcinoma patients.
DIGESTIVE AND LIVER DISEASE.
53,
2
(2021)
Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea.
LIVER CANCER.
10,
1
(2021)
Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY.
12,
1
단행본
(2005)
대한소화기학회 총서 2 간염.
군자출판사.
공동
(2004)
내과전공의를 위한 진료지침.
진기획.
공동
학술회의논문
(2017)
Clinical Characteristics, Potencial Etiology and Mode of Detection for Non-B Non-C Hepatocellular Carcinoma in Korea.
KDDW 2017.
대한민국
(2017)
Comparison of Treatment Efficacy between Entecavir (ETV) and Tenofovir Disoproxil Fumarate (TDF) in Treatment-naive Chronic Hepatitis B Patients: Long-term Real-world Experience.
KDDW 2017.
대한민국
(2015)
Locoregional therapy or liver transplantation forhepatocellular carcinoma fulfilling the Milan criteria.
소화기학회.
미국
(2015)
Locoregional therapy or liver transplantation forhepatocellular carcinoma fulfilling the Milan criteria.
소화기학회.
대한민국
(2015)
Discontinuation of Antiviral prophylaxis in Hepatitis B Virus Infected Patients Who Received Cytotoxic Chemotherapy: Outcomes and Predictors.
aasld.
미국
(2015)
Lamivudine vs. Entecavir for the newly diagnosed hepatitis B-virus related Hepatocellular carcinoma.
AASLD.
미국
(2015)
Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels..
AASDL.
미국
(2015)
Survival of hepatocellular carcinoma patients according to recommended treatment by the Barcelona Clinic Liver Cancer or Hong Kong Liver Cancer staging system in hepatitis B endemic area.
AASLD.
미국
(2015)
Survival and prognostic factors in patients with intermediate stage hepatocellular carcinoma (HCC) who were treated with repeated transarterial chemoembolization (TACE).
AASLD.
미국
(2015)
long term outcome after resection of intermediate hepatocellular carcinoma: comparison to transarterial chemoembolization.
AASLD.
미국
(2014)
Effect of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.
AASLD.
대한민국
(2014)
HBV DNA / Quantitative HBsAg level ratio, but not either quantitative HBsAg level or HBV DNA, can predict hepatocellular carcinoma development in HBsAg-nagative chronic hepatitis patients with HBV DNA ≥2000 IU/ml.
AASLD.
대한민국
(2014)
Incidental microscopic bile duct tumor thrombi in hepatocellular carcinoma after curative hepatectomy: A matched study.
AASLD.
미국
(2014)
Risk of development of hepatocellular carcinoma in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferse levels.
AASLD.
대한민국
(2014)
The importance of intrahepatic tumor in hepatocellular carcinoma with extrahepatic spread in patients treated with sorafenib.
AASLD.
대한민국
(2014)
Predictive factor of hepatocellular carcinoma in hbeag-negative chronic hepatitis patients: comparison of hbv dna/quantitative hbsag level ratio with quantitative hbsag level and hbv dna.
ILCA.
일본
(2014)
Sorafenib Therapy In hcc patients with extrahepatic spread: Treatment efficacy and prognostic factors.
ILCA.
일본
(2014)
Treatment of hepatocellular carcinoma in chld-pugh class c liver cirrhosis patients.
ILCA.
일본
(2014)
Virological response to Anti-viral therapy predicts the recurrence of HBV-related HCC after curative resection.
APPLE.
태국
(2014)
Comparison between transient elastography and noninvasive clinical methods for prediction of liver cirrhosis in patients with chronic liver disease.
The liver week 2014.
대한민국
